The American College of Radiology (ACR) has published a summary of the Centers for Medicare and Medicaid Services' (CMS) 2024 Transitional Coverage for Emerging Technologies (TCET) Pathway final procedure notice.
The TCET pathway uses national coverage determination (NCD) and coverage with evidence development processes to accelerate Medicare coverage of breakthrough devices. CMS released its final notice on the pathway on August 8, after which the ACR submitted comments regarding the TCET pathway.
CMS does not plan to accept more than five candidates into the pathway per year and nominations will be reviewed quarterly, according to the ACR's summary. CMS will finalize an NCD for technologies accepted into the TCET pathway within six months of a company securing U.S. Food and Drug Administration (FDA) market authorization.
CMS also intends to provide criteria for prioritizing TCET requests, with the agency holding a public comment period on its proposed approach.
The ACR's full summary can be found here.
